< Back

November, 2017

Customer Relationship Benchmarks: IDN Medical Directors

Market Access Customer Relationships| November 2017

Medical Directors Describe the Majority of Relationships as Partner or Collaborative

Out of 1,872 potential relationships with biopharmaceutical companies, IDN medical directors classify 23% as Partner and 24% as Collaborative.

To build Transactional-level relationships, companies should supplement product information with resources that support broader clinical challenges.

 

These and other findings can be found in Health Strategies Group’s recently released research Company Relationship Benchmarks–IDN Medical Directors.

 

Key questions answered in this research:

  • Where do relationships stand with IDN medical directors?
  • Which attributes help biopharmaceutical companies strengthen relationships with IDN medical directors?
  • Which companies receive the highest ratings in each cornerstone of the relationship?

View the Research

 

Visit our Market Access Customer Relationships webpage to learn more about this research.

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.